1-3 of 3
Cindy Kramer
Close
Sort by
Journal Articles

Similar Dynamics Of Intra Apheresis Autologous CD34+ Recruitment and Collection Efficiency In Patients Undergoing Mobilization With Or Without Plerixafor

Henning Schade, MD, Yubin Kang, MD., Chhabra Saurabh, MD, Robert K Stuart, Kathy H Edwards, PharmD, Cindy Kramer, RN, BSN, OCN, Mollie Schneider, RN, BSN, Amanda Littleton, RN, BSN, Katie B Shoptaw, RN, BSN, MSN, Luciano J Costa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 904.
https://doi.org/10.1182/blood.V122.21.904.904
Published: 2013
Journal Articles

Comparison Between Pegfilgrastim and Filgrastim-Based Autologous Hematopoietic Stem Cell Mobilization in the Setting of Patient Adapted (“Just in Time”) Plerixafor: Efficacy and Cost Analysis

Luciano J Costa, MD, PhD, Kathy Hogan, PharmD, Cindy Kramer, RN, BSN, OCN, Coleen Butcher, RN, BSN, Amanda Littleton, RN, BSN, Katie B Shoptaw, RN, BSN, MSN, Yubin Kang, MD., Robert K Stuart, MD
Journal: Blood
Blood (2011) 118 (21): 1921.
https://doi.org/10.1182/blood.V118.21.1921.1921
Published: 2011
Journal Articles

Excessive Rate of Late Infections and Treatment Related Mortality Associated with the Use of Alemtuzumab in Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Trial.

Munira Shabbir, MBBS, MD, Luciano J Costa, MD, PhD, Christine Schaub, FNP, Carrie Maxwell, Theo Fouts, RN, BSN, CPON, Ashley Miller, Cindy Kramer, Karen Rogers, Louan Russ, Emily Kistner-Griffin, Robert K Stuart, M.D.
Journal: Blood
Blood (2009) 114 (22): 2230.
https://doi.org/10.1182/blood.V114.22.2230.2230
Published: 2009